FDC (NSE:FDC) Total Receivables : ₹1,748 Mil (As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is FDC Total Receivables?

FDC's Total Receivables for the quarter that ended in Sep. 2024 was ₹1,748 Mil.

FDC Total Receivables Historical Data

The historical data trend for FDC's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Total Receivables Chart

FDC Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Receivables

Get a 7-Day Free Trial

1,432.28

1,171.13

849.67

1,243.53

1,252.24

FDC Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Receivables	Get a 7-Day Free Trial															1,598.65	-	1,252.24	-	1,748.03

FDC Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

FDC Total Receivables Related Terms

Thank you for viewing the detailed overview of FDC's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

FDC Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Total Receivables

Traded in Other Exchanges

531599:India

Address

106 A, J. P. Road, C-3 Skyvistas, D.N. Nagar, Near Versova Police Station, Andheri (West), Mumbai, MH, IND, 400053

Website

https://www.fdcindia.com

FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.